Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Delcath Systems, Inc. (DCTH : NSDQ)

• Company Description    Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. Number of Employees: 96

• Price / Volume Information    Yesterday's Closing Price: $11.32 Daily Weekly Monthly 20 Day Moving Average: 945,557 shares Shares Outstanding: 34.83 (millions) Market Capitalization: $394.23 (millions) Beta: 0.87 52 Week High: $18.23 52 Week Low: $7.17 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.06% -24.07% 12 Week -6.14% -18.25% Year To Date -5.98% -12.19%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 566 QUEENSBURY AVENUE - QUEENSBURY,NY 12804 USA ph: 518-743-8892 fax: 212-489-2102 investorrelations@delcath.com http://www.delcath.com

• General Corporate Information    Officers Gerard Michel - Chief Executive Officer and Director John R. Sylvester - Chairman of the Board Sandra Pennell - Chief Financial Officer Elizabeth Czerepak - Director Steven Salamon - Director Peer Information Delcath Systems, Inc. (ABMD) Delcath Systems, Inc. (DMDS) Delcath Systems, Inc. (CPWY.) Delcath Systems, Inc. (EQUR) Delcath Systems, Inc. (ECIA) Delcath Systems, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 24661P807 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/04/25 Share - Related Items Shares Outstanding: 34.83 Most Recent Split Date: 12.00 (0.00:1) Beta: 0.87 Market Capitalization: $394.23 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.33 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/25

• Fundamental Ratios P/E Current FY Estimate: 34.30 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.72 Price/Cash Flow: - Price / Sales: 7.32 EPS Growth vs. Year Ago Period: 106.98% vs. Previous Quarter: -40.00% Sales Growth vs. Year Ago Period: 530.26% vs. Previous Quarter: 31.02% ROE 06/30/25 - - 03/31/25 - -29.44 12/31/24 - -97.67 ROA 06/30/25 - - 03/31/25 - -20.75 12/31/24 - -52.67 Current Ratio 06/30/25 - - 03/31/25 - 15.95 12/31/24 - 12.01 Quick Ratio 06/30/25 - - 03/31/25 - 14.61 12/31/24 - 10.88 Operating Margin 06/30/25 - - 03/31/25 - -22.11 12/31/24 - -63.09 Net Margin 06/30/25 - - 03/31/25 - -26.38 12/31/24 - -70.92 Pre-Tax Margin 06/30/25 - - 03/31/25 - -26.02 12/31/24 - -70.92 Book Value 06/30/25 - - 03/31/25 - 2.40 12/31/24 - 2.15 Inventory Turnover 06/30/25 - - 03/31/25 - 1.20 12/31/24 - 1.05 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©